Description
Product Overview / 商品概要
Levocarnitine FF Injection 1000mg Syringe “FUSO” (レボカルニチンFF静注1000mgシリンジ「フソー」)
Generic: Levocarnitine / レボカルニチン
Therapeutic Category: Levocarnitine Preparation / レボカルニチン製剤
Manufactured by: Fuso Pharmaceutical Industries, Ltd. / 扶桑薬品工業株式会社
Composition & Specification / 組成・規格
Active Ingredient: Levocarnitine 1000mg per 1 syringe (5mL) / 1シリンジ中 レボカルニチン 1000mg
Additives: pH adjuster / pH調節剤
Appearance: Colorless to pale yellow clear solution; pH 6.0–6.5; osmotic pressure ratio (relative to normal saline) approximately 7
外観: 無色~微黄色澄明の液、pH 6.0~6.5、浸透圧比(生理食塩液に対する比)約7
Indications / 効能効果
EN: Carnitine deficiency
JA: カルニチン欠乏症
Dosage and Administration / 用法用量
EN: Generally, administer levocarnitine at 50mg per kg body weight per dose every 3 to 6 hours by slow intravenous injection (over 2–3 minutes) or intravenous drip infusion. Dose may be adjusted according to patient condition; the maximum daily dose is 300mg per kg body weight. For carnitine deficiency associated with hemodialysis, generally administer levocarnitine at 10–20mg per kg body weight at the end of each dialysis session via the venous side of the dialysis circuit (intravenous injection). Dose may be adjusted according to patient condition.
JA: 通常、レボカルニチンとして1回体重1kgあたり50mgを3~6時間ごとに、緩徐に静注(2~3分)又は点滴静注する。なお、患者の状態に応じて適宜増減するが、1日の最大投与量は体重1kgあたり300mgとする。血液透析に伴うカルニチン欠乏症に対しては、通常、レボカルニチンとして体重1kgあたり10~20mgを透析終了時に、透析回路静脈側に注入(静注)する。なお、患者の状態に応じて適宜増減する。
Contraindications / 禁忌
EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者
Regulatory Information / 規制情報
Approval No.: 30400AMX00114
Sales Started: June 2022 / 2022年6月
Classification Code: 873999
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 5mL x 10 syringes / 5mL 10シリンジ
Other Available Packages (by special order): (Luer lock type) 5mL x 10 syringes
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.


![Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)](https://jp-pharma.com/wp-content/uploads/2026/06/OFL-03-OTC_1200x1200-324x324.jpg)

Reviews
There are no reviews yet.